Copyright
©The Author(s) 2023.
World J Virol. Sep 25, 2023; 12(4): 221-232
Published online Sep 25, 2023. doi: 10.5501/wjv.v12.i4.221
Published online Sep 25, 2023. doi: 10.5501/wjv.v12.i4.221
Variables | Alcoholic cirrhosis | No alcoholic cirrhosis (before matching) | P value | No alcoholic cirrhosis (after matching) | P value |
n | 1325 | 736685 | 1135 | ||
Asthma exacerbation | 5 (0.4) | 13170 (1.8) | < 0.001 | 5 (0.4) | 0.81 |
ARDS | 80 (6.0) | 31970 (4.3) | 0.002 | 100 (8.8) | 0.008 |
Type I respiratory failure | 545 (41.1) | 379975 (51.6) | < 0.001 | 475 (41.9) | 0.72 |
Type II respiratory failure | 15 (1.1) | 7640 (1.0) | 0.73 | 15 (1.3) | 0.67 |
Bacterial pneumonia | 10 (0.8) | 6005 (0.8) | 0.81 | 10 (0.9) | 0.73 |
Klebsiella pneumonia | 0 (0.0) | 1425 (0.2) | 0.11 | 0 (0.0) | - |
Streptococcus pneumonia | 0 (0.0) | 805 (0.1) | 0.23 | 0 (0.0) | - |
Staphylococcus pneumonia | 5 (0.4) | 3850 (0.5) | 0.46 | 10 (0.9) | 0.11 |
Hemophilus pneumonia | 5 (0.4) | 300 (< 1) | < 0.001 | 0 (0.0) | - |
Anosmia | 0 (0.0) | 1240 (0.2) | 0.14 | 0 (0.0) | - |
Hemorrhagic CVA | 0 (0.0) | 615 (0.1) | 0.29 | 0 (0.0) | - |
Ischemic CVA | 0 (0.0) | 475 (0.1) | 0.36 | 0 (0.0) | - |
Dysgeusia | 0 (0.0) | 695 (0.1) | 0.26 | 0 (0.0) | - |
Diarrhea | 80 (6.0) | 44110 (6.0) | 0.94 | 65 (5.7) | 0.74 |
Septic shock | 75 (5.7) | 21780 (3.0) | < 0.001 | 47 (4.1) | 0.007 |
SVT | 30 (2.3) | 9375 (1.3) | 0.001 | 25 (2.2) | 0.92 |
VT | 20 (1.5) | 10065 (1.4) | 0.65 | 40 (3.5) | 0.001 |
Vfib/Vflutter | 5 (0.4) | 1315 (0.2) | 0.087 | 0 (0.0) | 0.038 |
Afib | 175 (13.2) | 77340 (10.5) | 0.001 | 100 (8.8) | < 0.001 |
Aflutter | 115 (8.7) | 47410 (6.4) | < 0.001 | 50 (4.4) | < 0.001 |
First-degree AV nodal block | 10 (0.8) | 3250 (0.4) | 0.086 | 0 (0.0) | 0.003 |
Second-degree AV nodal block | 0 (0.0) | 1515 (0.2) | 0.098 | 0 (0.0) | - |
Complete AV nodal block | 0 (0.0) | 1375 (0.2) | 0.12 | 10 (0.9) | < 0.001 |
ECMO | 0 (0.0) | 120 (< 1) | 0.64 | 0 (0.0) | - |
Total acute VTE | 50 (3.8) | 26120 (3.5) | 0.65 | 75 (6.6) | 0.001 |
Portal venous thrombosis | 5 (0.4) | 190 (< 1) | < 0.001 | 15 (1.3) | 0.009 |
Budd Chiari | 0 (0.0) | 35 (< 1) | 0.80 | 0 (0.0) | - |
Upper extremity VTE | 20 (1.5) | 1960 (0.3) | < 0.001 | 0 (0.0) | < 0.001 |
Lower extremity VTE | 10 (0.8) | 8050 (1.1) | 0.24 | 10 (0.9) | 0.73 |
Other VTE | 10 (0.8) | 1285 (0.2) | < 0.001 | 5 (0.4) | 0.32 |
Pulmonary embolism | 20 (1.5) | 18055 (2.5) | 0.027 | 50 (4.4) | < 0.001 |
Variceal bleeding | 50 (3.8) | 100 (< 1) | < 0.001 | 0 (0.0) | < 0.001 |
Hepatorenal syndrome | 5 (0.4) | 140 (< 1) | < 0.001 | 15 (1.3) | 0.009 |
Hyponatremia | 325 (24.5) | 123080 (16.7) | < 0.001 | 285 (25.1) | 0.74 |
Pulmonary hypertension | 280 (21.1) | 1210 (0.2) | < 0.001 | 75 (6.6) | < 0.001 |
Spontaneous bacterial peritonitis | 15 (1.1) | 35 (< 1) | < 0.001 | 5 (0.4) | 0.057 |
Acute liver failure | 4 (0.34) | 303 (0.45) | < 0.001 | 4 (0.30) | 0.82 |
New HD | 2 (0.15) | 750 (0.11) | < 0.001 | 0 (0) | 0.1 |
- Citation: Inayat F, Ali H, Patel P, Dhillon R, Afzal A, Rehman AU, Afzal MS, Zulfiqar L, Nawaz G, Goraya MHN, Subramanium S, Agrawal S, Satapathy SK. Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States. World J Virol 2023; 12(4): 221-232
- URL: https://www.wjgnet.com/2220-3249/full/v12/i4/221.htm
- DOI: https://dx.doi.org/10.5501/wjv.v12.i4.221